Yale New Haven investment leader departs

Scott Lupkas has left his role as vice president of investments for Yale New Haven (Conn.) Health after 18 months in the position, a spokesperson for the health system confirmed to Becker’s.

Advertisement

Yale New Haven Health hired Mr. Lupkas in February 2022 to oversee investment strategy for its nearly $6 billion in investment assets and “further develop an in-house investment team” that supports the treasurer, CFO and system investment committee in the stewardship of assets.

However, since Mr. Lupkas joined the system, three team members departed, according to the Institutional Investor. Geeta Kapadia, associate treasurer of investments, resigned from her post in June 2022. She was appointed chief investment officer at Fordham University in New York City two months later. 

Two other investment team members, Mallika Nair and David Pearson, joined Ms. Kapadia at Fordham about a year later, according to the Institutional Investor.

Yale New Haven did not provide details on Mr. Lupkas’s departure. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.